Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V; Perinatal HIV Prevention Trial (Thailand) Investigators. Lallemant M, et al. N Engl J Med. 2004 Jul 15;351(3):217-28. doi: 10.1056/NEJMoa033500. Epub 2004 Jul 9. N Engl J Med. 2004. PMID: 15247338 Free article. Clinical Trial.
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, Ariyadej S, Leenasirimakul P, Hammer S, Lallemant M; Perinatal HIV Prevention Trial Group. Jourdain G, et al. Among authors: lallemant m. N Engl J Med. 2004 Jul 15;351(3):229-40. doi: 10.1056/NEJMoa041305. Epub 2004 Jul 9. N Engl J Med. 2004. PMID: 15247339 Free article. Clinical Trial.
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M. Cressey TR, et al. Among authors: lallemant mj. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):283-8. J Acquir Immune Defic Syndr. 2005. PMID: 15735445 Clinical Trial.
Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1.
Barin F, Jourdain G, Brunet S, Ngo-Giang-Huong N, Weerawatgoompa S, Karnchanamayul W, Ariyadej S, Hansudewechakul R, Achalapong J, Yuthavisuthi P, Ngampiyaskul C, Bhakeecheep S, Hemwutthiphan C, Lallemant M; Perinatal HIV Prevention Trial Group. Barin F, et al. Among authors: lallemant m. J Infect Dis. 2006 Jun 1;193(11):1504-11. doi: 10.1086/503778. Epub 2006 Apr 21. J Infect Dis. 2006. PMID: 16652277
Maternal HIV-1 DNA load and mother-to-child transmission.
Arvold ND, Ngo-Giang-Huong N, McIntosh K, Suraseranivong V, Warachit B, Piyaworawong S, Changchit T, Lallemant M, Jourdain G; Perinatal HIV Prevention Trial (PHPT-1), Thailand. Arvold ND, et al. Among authors: lallemant m. AIDS Patient Care STDS. 2007 Sep;21(9):638-43. doi: 10.1089/apc.2006.0169. AIDS Patient Care STDS. 2007. PMID: 17919090 Clinical Trial.
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M; Perinatal HIV Prevention Trial Group, Thailand. Jourdain G, et al. Among authors: lallemant m. J Infect Dis. 2007 Dec 1;196(11):1629-36. doi: 10.1086/522009. Epub 2007 Oct 25. J Infect Dis. 2007. PMID: 18008246 Clinical Trial.
206 results